Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Hits New 1-Year High - Here's Why

Key Points

• Bayer Aktiengesellschaft shares have reached a new 52-week high of $8.68, reflecting increased investor interest and trading volume.
• Analysts show mixed opinions on BAYRY, with Zacks lowering their rating to "hold," while several other firms upgraded it to "strong-buy."
• The company reported $12.42 billion in revenue for its latest quarter, outperforming expectations and posting a 15.44% return on equity.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) shares reached a new 52-week high on Wednesday . The stock traded as high as $8.68 and last traded at $8.67, with a volume of 507672 shares traded. The stock had previously closed at $8.29.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on BAYRY shares. Zacks Research lowered Bayer Aktiengesellschaft from a "strong-buy" rating to a "hold" rating in a report on Monday, September 1st. Kepler Capital Markets upgraded Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a report on Wednesday, June 11th. Hsbc Global Res upgraded Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Wednesday, June 11th. The Goldman Sachs Group upgraded Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Finally, Wall Street Zen upgraded Bayer Aktiengesellschaft from a "buy" rating to a "strong-buy" rating in a report on Tuesday, August 19th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, Bayer Aktiengesellschaft presently has a consensus rating of "Buy".

Bayer Aktiengesellschaft Stock Up 4.9%

The business has a 50-day simple moving average of $8.06 and a two-hundred day simple moving average of $7.31. The stock has a market capitalization of $34.19 billion, a P/E ratio of -8.97, a PEG ratio of 3.68 and a beta of 0.93. The company has a quick ratio of 0.73, a current ratio of 1.13 and a debt-to-equity ratio of 1.04.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.35 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.10. Bayer Aktiengesellschaft had a positive return on equity of 15.44% and a negative net margin of 7.61%.The firm had revenue of $12.42 billion for the quarter, compared to analysts' expectations of $10.79 billion. Equities research analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.